Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Oral Oncology
|
July 11, 1998
Scoring oral mucositis
W Parulekar, R Mackenzie, G Bjarnason, et al.
Chest
|
July 14, 2001
Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions
W Parulekar, G Di Primio, F Matzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2024
Reply to 'Letter to the Editor regarding "Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]", by C. C. Parker et al.'
C C Parker, C N Catton, N Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain
D S Ernst, I F Tannock, E W Winquist, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo
M M Vickers, E D Powell, T R Asmis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 16, 2007
RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery)
C Parker, N Clarke, J Logue, et al.
NPJ Breast Cancer
|
August 29, 2025
Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial
N Riaz, B E Chen, A Bane, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 7, 2005
Defining the need for local therapy in locally advanced prostate cancer: an appraisal of the MRC PR07 study
M Mason, P Warde, M Sydes, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3
M M Vickers, C Lee, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
W Xie, P Ravi, M Buyse, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Oral Oncology
|
July 11, 1998
Scoring oral mucositis
W Parulekar, R Mackenzie, G Bjarnason, et al.
Chest
|
July 14, 2001
Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions
W Parulekar, G Di Primio, F Matzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2024
Reply to 'Letter to the Editor regarding "Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]", by C. C. Parker et al.'
C C Parker, C N Catton, N Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain
D S Ernst, I F Tannock, E W Winquist, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo
M M Vickers, E D Powell, T R Asmis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 16, 2007
RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery)
C Parker, N Clarke, J Logue, et al.
NPJ Breast Cancer
|
August 29, 2025
Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial
N Riaz, B E Chen, A Bane, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 7, 2005
Defining the need for local therapy in locally advanced prostate cancer: an appraisal of the MRC PR07 study
M Mason, P Warde, M Sydes, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3
M M Vickers, C Lee, D Tu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
W Xie, P Ravi, M Buyse, et al.
Page
of 2